Sanarus

Kate Madden Yee
Nov 6, 2005
2005 11 04 16 53 05 706

Pleasanton, CA-based Sanarus will highlight two products at this year's RSNA show: its Cassi Rotational Core Biopsy Device and Visica Treatment System. Both offerings were cleared by the FDA in 2004, and use the company's proprietary cryo technology.

2005 11 04 16 53 05 706

Cassi is a handheld, large-core biopsy device. Fully automated, it incorporates Sanarus's Stick-Freeze technology, which immobilizes the lesion for precise sampling of large tissue samples with fewer passes. Cassi is also disposable.

Visica is an in-office, ultrasound-guided, minimally invasive procedure that uses cryoablation technology to destroy fibroadenomas.

By Kate Madden Yee
AuntMinnie.com contributing writer
November 7, 2005

Copyright © 2005 AuntMinnie.com

Latest in Breast
Sectra Rsna 2019 400
Sectra inks 5-year deal with MaineGeneral Health
October 15, 2024
Breast Cancer
New theranostics pairing tested in breast cancer patients
July 31, 2024
Mri Breast Cancer
Black women less likely to undergo preoperative breast MRI
July 10, 2024
Erik Anderson thumb
Breakthroughs in cancer breast screening technologies
July 5, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
Rsna
Market research reports
RSNA
2005 11 04 16 51 35 706
Breast
R2 Technology
2005 11 04 16 50 09 706
Breast
Planmed
More in Breast
Sectra inks 5-year deal with MaineGeneral Health
By AuntMinnie.com staff writers
Sectra has secured a five-year agreement with MaineGeneral Health to use Sectra One Cloud and its modules for radiology and breast imaging.
October 15, 2024
Sectra Rsna 2019 400
New theranostics pairing tested in breast cancer patients
By Kate Madden Yee
A new theranostics pairing of molecular imaging and radioligand therapy shows promise as a treatment option for patients with metastatic breast cancer, researchers have found.
July 31, 2024
Breast Cancer
Black women less likely to undergo preoperative breast MRI
By Kate Madden Yee
Black women diagnosed with breast cancer are less likely than their white counterparts to undergo preoperative MRI, researchers report.
July 10, 2024
Mri Breast Cancer
Breakthroughs in cancer breast screening technologies
By Erik Anderson
Erik Anderson of women's imaging vendor Hologic discusses the impact of recent technological advances for detecting and diagnosing breast cancer.
July 5, 2024
Erik Anderson thumb
Uniting for health equity: Addressing breast cancer disparities
By Dana Brown
Juneteenth marks the emancipation of enslaved people in the U.S. and is a time to reflect on both the progress toward equality and the disparities that remain.
June 19, 2024
Black Women Hands Mammography
Critics slam Canadian breast screening guidelines
By Amerigo Allegretto
Breast imaging advocates and political bodies are criticizing updated guidelines on breast cancer screening by the CTFPHC.
May 31, 2024
Canada Montreal Skyline 400
FES-PET could save $142M in breast cancer costs
By Will Morton
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor-positive breast cancer could save millions.
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
By Will Morton
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma.
May 17, 2024
Breast Mol
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
By Liz Carey
A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.
May 6, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
USPSTF finalizes breast cancer screening recommendations
By Liz Carey
The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.
April 30, 2024
Mammogram Breast
Large language models underperform in breast imaging
By Amerigo Allegretto
Large language models such as ChatGPT and Google Gemini fall short in breast imaging.
April 30, 2024
Screenshot (1152)
Page 1 of 570
Next Page